Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Biliary Tract Neoplasms × pamiparib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Ovarian Neoplasms 5 Neoplasms 4 Glioblastoma 4 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Solid Tumors 1 Solid Tumor 1 Rare Tumour 1 Neuroectodermal Tumors 1 Nervous System Diseases 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Neoadjuvant Therapy 1 Metastatic Castration-resistant Prostate Cancer 1 Metastatic Castration-Resistant Prostate Cancer (mCRPC) 1 Locally Advanced Prostate Cancer 1 Limited Stage Small Cell Lung Cancer 1 Hereditary leiomyomatosis and renal cell cancer 1 HER2-negative Breast Cancer 1 Gliosarcoma 1 Glioma 1 For Participants With Advanced Solid Tumors Failed With Previous Lines of Treatment 1 Central Nervous System Neoplasms 1 Carcinosarcoma 1 Carcinoma, Renal Cell 1 Carcinoma, Ovarian Epithelial 1 Brain Neoplasms 1 Biliary Tract Neoplasms 1 Astrocytoma 1 Advanced Malignant Solid Neoplasm 1

Interventions

Gemcitabine 78 Cisplatin 62 Capecitabine 32 Oxaliplatin 30 durvalumab 24 Fluorouracil 22 pembrolizumab 21 Leucovorin 20 S 1 (combination) 14 Irinotecan 12 lenvatinib 10 Nivolumab 10 Bevacizumab 9 130-nm albumin-bound paclitaxel 9 tremelimumab 7 Injections 7 Immune Checkpoint Inhibitors 7 Docetaxel 7 apatinib 6 Trastuzumab 6 surufatinib 5 irinotecan sucrosofate 5 camrelizumab 5 Folfox protocol 5 Carboplatin 5 Blood Specimen Collection 5 Albumin-Bound Paclitaxel 5 titanium silicide 4 gemcitabine-oxaliplatin regimen 4 envafolimab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04796454 2022-06-01

PAMICC

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Withdrawn

Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡